BKMIX
Price
$10.71
Change
+$0.01 (+0.09%)
Updated
Aug 21 closing price
Net Assets
10.49B
GSBCX
Price
$27.35
Change
+$0.05 (+0.18%)
Updated
Aug 21 closing price
Net Assets
2.83B
Interact to see
Advertisement

BKMIX vs GSBCX

BKMIX vs GSBCX Comparison Chart in %
View a ticker or compare two or three
VS
BKMIX vs. GSBCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKMIX is a StrongBuy and GSBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BKMIX has more cash in the bank: 10.5B vs. GSBCX (2.83B). BKMIX pays higher dividends than GSBCX: BKMIX (6.06) vs GSBCX (3.25). BKMIX was incepted earlier than GSBCX: BKMIX (10 years) vs GSBCX (29 years). GSBCX (1.69) is less costly to investors than BKMIX (0.62). BKMIX is a more actively managed with annual turnover of: 99.00 vs. GSBCX (33.00). GSBCX has a lower initial minimum investment than BKMIX: GSBCX (1000) vs BKMIX (5000000). GSBCX annual gain was more profitable for investors over the last year : 9.90 vs. BKMIX (8.66). BKMIX (23.36) and GSBCX (22.49) have equivalent 5 years return.
BKMIXGSBCXBKMIX / GSBCX
Total Expense Ratio0.521.5633%
Annual Report Gross Expense Ratio0.621.6937%
Fund Existence10 years29 years-
Gain YTD5.1517.27671%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/A250-
Net Assets10.5B2.83B371%
Annual Yield % from dividends6.063.25187%
Returns for 1 year8.669.9087%
Returns for 3 years35.0635.19100%
Returns for 5 years23.3622.49104%
Returns for 10 yearsN/A71.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIDIX15.920.16
+1.02%
Principal International EQ Index Instl
LKINX17.750.17
+0.97%
LKCM International Equity
FSGAX48.950.33
+0.68%
Franklin Small-Mid Cap Growth Adv
DRAFX2.850.01
+0.35%
Destinations Real Assets I
JUSRX28.630.08
+0.28%
JPMorgan US Equity R5